Medmarc at 45: Why This Specialty Insurer Remains a Quiet Constant in MedTech’s Shifting Terrain

We are pleased to share that Medmarc was recently featured in an article published by MedTech World. 

 

 

Insurance may not be the flashiest part of the MedTech ecosystem, but for companies developing high-risk devices and drugs, the right coverage is often the difference between scale and setback. That’s where Medmarc comes in. 

Founded in 1979 to serve the unique liability needs of the life sciences sector, Medmarc has quietly built a reputation as a long-term ally to MedTech and pharmaceutical companies navigating product risk, litigation, and regulatory complexity. Now entering its 46th year, the firm continues to specialize exclusively in product liability and errors and omissions (E&O) insurance for manufacturers—choosing depth over breadth in an increasingly fragmented market. 

“Our mission has always been to be the superior provider of liability insurance, claims handling, and risk management services to the industry,” says Lynn Carney, Director of Agency and Alliances at Medmarc. “The products and risks have evolved, and we’ve adapted with them—but our purpose hasn’t shifted.”